A phase II, randomized, placebo-controlled study of the immunogenicity, safety and reactogenicity of an orally administered human rotavirus vaccine (RIX4414) in healthy infants in Bangladesh

Simple item page
dc.contributor.authorZaman, K.
dc.date.accessioned2014-07-13T05:30:44Z
dc.date.available2014-07-13T05:30:44Z
dc.date.issued2004
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/5159
dc.identifier.urihttp://hdl.handle.net/123456789/5159
dc.language.isoen
dc.publisherDhaka: International Centre for Diarrhoeal Diseases Research, Bangladesh; 2004
dc.sourceICDDR,B Institutional Repository
dc.subjectClinical protocols
dc.subjectRotavirus vaccines
dc.subjectDiarrhoeal diseases
dc.subjectBangladesh
dc.titleA phase II, randomized, placebo-controlled study of the immunogenicity, safety and reactogenicity of an orally administered human rotavirus vaccine (RIX4414) in healthy infants in Bangladesh
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ICDDRBProtocol-2004-050.doc
Size:
518 KB
Format:
Adobe Portable Document Format
Download

Collections

Child health research protocols